Milestone Pharmaceuticals Statistics
Total Valuation
MIST has a market cap or net worth of $161.22 million. The enterprise value is $114.33 million.
| Market Cap | 161.22M |
| Enterprise Value | 114.33M |
Important Dates
The next estimated earnings date is Tuesday, August 11, 2026, before market open.
| Earnings Date | Aug 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MIST has 136.05 million shares outstanding. The number of shares has increased by 50.78% in one year.
| Current Share Class | 119.64M |
| Shares Outstanding | 136.05M |
| Shares Change (YoY) | +50.78% |
| Shares Change (QoQ) | +22.87% |
| Owned by Insiders (%) | 0.83% |
| Owned by Institutions (%) | 22.69% |
| Float | 118.51M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 90.37 |
| Forward PS | 13.39 |
| PB Ratio | 4.41 |
| P/TBV Ratio | 4.47 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 64.09 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.18, with a Debt / Equity ratio of 3.81.
| Current Ratio | 9.18 |
| Quick Ratio | 9.03 |
| Debt / Equity | 3.81 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -9.28 |
Financial Efficiency
Return on equity (ROE) is -456.88% and return on invested capital (ROIC) is -36.62%.
| Return on Equity (ROE) | -456.88% |
| Return on Assets (ROA) | -31.92% |
| Return on Invested Capital (ROIC) | -36.62% |
| Return on Capital Employed (ROCE) | -37.78% |
| Weighted Average Cost of Capital (WACC) | 7.04% |
| Revenue Per Employee | $46,947 |
| Profits Per Employee | -$1.80M |
| Employee Count | 38 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -29.04% in the last 52 weeks. The beta is 0.97, so MIST's price volatility has been similar to the market average.
| Beta (5Y) | 0.97 |
| 52-Week Price Change | -29.04% |
| 50-Day Moving Average | 1.39 |
| 200-Day Moving Average | 1.81 |
| Relative Strength Index (RSI) | 35.62 |
| Average Volume (20 Days) | 1,324,569 |
Short Selling Information
The latest short interest is 12.60 million, so 9.26% of the outstanding shares have been sold short.
| Short Interest | 12.60M |
| Short Previous Month | 10.60M |
| Short % of Shares Out | 9.26% |
| Short % of Float | 10.63% |
| Short Ratio (days to cover) | 8.69 |
Income Statement
In the last 12 months, MIST had revenue of $1.78 million and -$68.36 million in losses. Loss per share was -$0.68.
| Revenue | 1.78M |
| Gross Profit | 1.77M |
| Operating Income | -65.28M |
| Pretax Income | -68.36M |
| Net Income | -68.36M |
| EBITDA | -65.14M |
| EBIT | -65.28M |
| Loss Per Share | -$0.68 |
Balance Sheet
The company has $184.22 million in cash and $137.33 million in debt, with a net cash position of $46.89 million or $0.34 per share.
| Cash & Cash Equivalents | 184.22M |
| Total Debt | 137.33M |
| Net Cash | 46.89M |
| Net Cash Per Share | $0.34 |
| Equity (Book Value) | 36.05M |
| Book Value Per Share | 0.27 |
| Working Capital | 171.31M |
Cash Flow
In the last 12 months, operating cash flow was -$51.14 million and capital expenditures -$341,000, giving a free cash flow of -$51.48 million.
| Operating Cash Flow | -51.14M |
| Capital Expenditures | -341,000 |
| Depreciation & Amortization | 143,000 |
| Net Borrowing | 74.99M |
| Free Cash Flow | -51.48M |
| FCF Per Share | -$0.38 |
Margins
| Gross Margin | 99.22% |
| Operating Margin | -3,659.19% |
| Pretax Margin | -3,832.01% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
MIST does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -50.78% |
| Shareholder Yield | -50.78% |
| Earnings Yield | -42.40% |
| FCF Yield | -31.93% |
Analyst Forecast
The average price target for MIST is $6.33, which is 434.18% higher than the current price. The consensus rating is "Buy".
| Price Target | $6.33 |
| Price Target Difference | 434.18% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (3Y) | 341.64% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MIST has an Altman Z-Score of -2.72 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.72 |
| Piotroski F-Score | 2 |